Month: June 2020

Sbanken ASA, NO0010886757, Issue Date: 26.06.2020, FRN Sbanken ASA Bond Issue 2020/2023. Maturity date: 26.09.2023, Initial Amount: NOK 300.000.000,-. Maximum Amount: NOK 1.000.000.000,-. The Bond will be listed on Nordic ABM.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

CALGARY, Alberta, June 24, 2020 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (the “Corporation” or the “Company” or “CEMATRIX”), a North American leading manufacturer and supplier of technologically advanced cellular concrete products through its wholly owned operating subsidiaries, CEMATRIX (Canada) Inc. (“CCI”), MixOnSite USA Inc. (“MOS”) and Pacific International Grout Company (“PIGCO’) today announced that  it is scheduled to present at Sidoti’s Inaugural Microcap Virtual Conference on June 30, 2020.Jeff Kendrick, CEO will present the CEMATRIX business to investors at 2:30PM ET, followed by a live Q&A session with investors and other conference attendees.  The investor presentation will be webcast live and is available at the following link.https://us02web.zoom.us/webinar/register/WN_hlAu7hvwQOW8_giNJy9UMg A live link...

NEW YORK, June 24, 2020 (GLOBE NEWSWIRE) — via NetworkWire — International Spirits & Wellness Holdings Inc. (“ISW Holdings”) (OTC: ISWH) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.To view the full publication, “The New Gold Rush Isn’t Gold,” visit: http://nnw.fm/VYjy8.In a bold foray into the new gold rush, International Spirits & Wellness Holdings Inc. (“ISW Holdings”) (OTC: ISWH) (ISWH Profile) recently announced a strategic partnership with Bit5ive LLC, a global leader in cryptocurrency mining and innovative turnkey mining solutions. ISW Holdings looks to combine this joint venture with its current renewable energy project to provide...

24 June 2020Announcement no. 30/2020Changes in Group ManagementExecutive Vice President of Private, Rasmus Lynge, leaves Alm. Brand.“Rasmus Lynge has made great efforts in developing and transforming our company. We now need to take the next important steps to meet our ambitious goals, and this is the right time to obtain a fresh view on our activities. I would like to thank Rasmus Lynge for his contribution to Alm. Brand, and I wish him the best of luck in the future”, says CEO Rasmus Werner Nielsen.With effect from today, Mikael Hvolgaard, Director of Price, Product and Portfolio in Private, has been appointed as Head of Private and member of Group Management. Thus, he will be in charge of this business area until a new Executive Vice President is found.The search process for the new head of Private has now been initiated.Please direct...

24. juni 2020Selskabsmeddelelse nr. 30/2020Ændringer i koncernledelsenKoncerndirektør for forretningsområdet Privat, Rasmus Lynge, forlader Alm. Brand.”Rasmus Lynge har gjort en stor indsats i arbejdet med at udvikle og transformere vores virksomhed. Vi skal nu tage de næste vigtige skridt for at indfri vores ambitiøse mål, og det er nu det rette tidspunkt at få nye øjne på vores aktiviteter. Jeg vil gerne takke Rasmus Lynge for hans bidrag til Alm. Brand, og jeg ønsker ham held og lykke fremover”, siger adm. direktør Rasmus Werner Nielsen.Med virkning fra i dag er Mikael Hvolgaard, direktør for Pris, Produkt og Portefølje i Privat, konstitueret som leder af Privat og medlem af koncernledelsen. Han vil således stå i spidsen for forretningsområdet, indtil der er fundet en ny koncerndirektør.Processen med at finde den fremtidige leder af...

Global WholeHealth Partners Corp. (OTC MKTS: GWHP) announced today that an application for Emergency Use Authorization (EUA) is under review at the U.S. Food and Drug Administration (FDA) for its “Made in the USA” Antibody IgM/IgG in vitro diagnostic test kit for the independent detection of IgG and IgM antibodies in Serum/Plasma and Whole Blood of patients exposed to the SARS-CoV-2 virus.SAN DIEGO, CA, June 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Global WholeHealth Partners Corp. (GWHP) submitted an Emergency Use Authorization (EUA) Application Submission Number EUA200181 for a “Made In the USA” COVID-19 Diagnostic Test for the Detection of Antibodies of SARS-CoV-2 on April 6 as mentioned in the 8K filing dated April 10, 2020.Forward-Looking StatementsThis press release contains “forward-looking...

TORONTO, June 24, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, today announced it has arranged a non-brokered private placement offering of up to 900,000 common shares priced at $1.50 per common share (the “Common Shares”) for gross proceeds of $1,000,000 USD (approximately $1,350,000 CAD) (the “Offering”).The proceeds of the Offering will be used to support the Phase II trial for its lead drug Metablok (LSALT peptide) to prevent acute lung and kidney injury experienced by patients with COVID-19.The Offering is expected to close on or before June 30, 2020 and is subject to certain conditions including, but not limited to, the receipt of applicable regulatory approvals,...

RICHMOND, Va., June 24, 2020 (GLOBE NEWSWIRE) — ALR Technologies Inc. (OTCQB: ALRT) today announces that the ALRT Diabetes Solution will be available to diabetes patients through their private physicians across Singapore. ALRT Diabetes Solution is a diabetes management platform that offers a comprehensive approach to diabetes and includes Bionime’s Rightest GM700SB blood glucose meter and test strips.The partnership with Bionime Corporation (“Bionime”) (TPE:4737) includes Bionime’s marketing team calling on the private physician practices in Singapore and the larger private practice groups. Founded in 2003, Bionime provides best quality products to people with healthcare need and their care givers, so that they can easily manage their daily health.The ALRT Diabetes Solution mitigates and contains diabetes complications by helping...

Polarcus Limited (“Polarcus” or the “Company”) (OSE: PLCS) refers to its announcement dated 14 January 2020 regarding the scheduled redelivery of “Vyacheslav Tikhonov” (the “Vessel”).The Vessel has completed the earlier referenced project in Asia. In light of further project opportunities, the charterers, Sovcomflot, have withdrawn their notice of redelivery. Polarcus will not receive charter hire from 31 May 2020 until startup of a new project anticipated to commence in Q3 2020. Redelivery of the Vessel is now expected to be following completion of the new project, or alternatively, on short notice if no project is awarded for the Vessel in the summer season. ContactsHans-Peter Burlid, CFO+971 50 559 8175hp.burlid@polarcus.com About PolarcusThis information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian...

REDWOOD CITY, Calif., June 24, 2020 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 30,303,030 shares of its common stock at a public offering price of $1.65. Soleno has also granted the underwriters a 30-day option to purchase up to 4,545,454 additional shares of common stock, at the public offering price, less underwriting discounts and commissions.  The gross proceeds of the offering are expected to be approximately $50 million, before deducting the underwriting discount and other estimated offering expenses. The closing of the offering is expected to occur on or about June 26, 2020, subject to the satisfaction of...